KOE:067630
HLB Life Science Co., Ltd. · KOE · Healthcare · KRW · FY for 2025
Figures on this page computed 2026-11-08 13:25 UTC
Last close
n/aKRW
Market data
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
-4.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-218.2%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
-106.0%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.54Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
Growth is the furthest below its sector's middle: 0.04 against 0.50 on the market's range.
- Growth-13.0%4 of 100, below its sector
- Returns on capital-4.7%21 of 100, below its sector
- Margins-4.5%12 of 100, below its sector
- Price1.1x42 of 100, above its sector
- Safety0.5430 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales0.53x
Its own average over 10 years, 85.60B.
- Profit3.80x
Its own average over 10 years, -26.31B.
- Free cash flow1.80x
Its own average over 10 years, -27.03B.
- Debt2.13x
Its own average over 10 years, 75.44B.
- Pricen/a
Its own average over 0 years. Market data
Profit is furthest from its own average, at 3.80 times.
Sales is 0.53 times its own 10-year average; Profit is 3.80 times its own 10-year average; Free cash flow is 1.80 times its own 10-year average; Debt is 2.13 times its own 10-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales against its own 10-year average0.53
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Profit against its own 10-year average3.80
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Free cash flow against its own 10-year average1.80
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Debt against its own 10-year average2.13
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- KRW